Stark, Alexander <br/><br/>
Somatostatin inhibits glucagon-like peptide-1-induced insulin secretion and proliferation of RINm5F insulinoma cells.  [electronic resource] 

 -  Regulatory peptides  Oct 2002 
 - 97-102 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0167-0115 
<br/><br/><label>Standard No.: </label>10.1016/s0167-0115(02)00152-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Division--drug effects<br/>Cyclic AMP--metabolism<br/>Cyclic AMP Response Element-Binding Protein--drug effects<br/>Disease Models, Animal<br/>Drug Interactions<br/>Glucagon--antagonists & inhibitors<br/>Glucagon-Like Peptide 1<br/>Insulin--metabolism<br/>Insulin Secretion<br/>Insulinoma<br/>Pancreatic Neoplasms<br/>Peptide Fragments--antagonists & inhibitors<br/>Protein Precursors--antagonists & inhibitors<br/>Rats<br/>Somatostatin--pharmacology<br/>Transcription Factors--drug effects<br/>Tumor Cells, Cultured